#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2884	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2488	344.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1666	1666	C	438	C,A	356,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2884	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2488	344.4	0	HET	.	.	.	T1412TGGGGG,TGGGG	.	1412	1412	T	1894	1894	T	413	TGGGGG,TGGGG	283,89	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	2884	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2488	344.4	0	HET	.	.	.	A37T	.	37	37	A	519	519	A	413	A,T	284,77	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4486	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3729	358.2	0	.	n	.	0	T695C	SNP	695	695	T	1135	1135	C	358	C	292	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4486	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3729	358.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1777	1777	A	399	A	337	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4486	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3729	358.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2411	2411	C	441	C	380	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4486	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3729	358.2	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3037	3037	T	356	T	299	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4486	23S	2890	2890	99.86	23S.l6.c4.ctg.1	3729	358.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2485	2485	A	443	A,G,C	363,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	458	folP	852	852	100.0	folP.l15.c4.ctg.1	2052	66.8	1	SNP	p	R228S	1	.	.	682	684	AGC	1284	1286	AGC	86;85;85	A;G;C	74;72;68	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	996	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3854	77.5	1	SNP	p	S91F	0	.	.	271	273	TCC	902	904	TCC	85;85;85	T;C;C	64;68;66	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	996	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3854	77.5	1	SNP	p	D95G	0	.	.	283	285	GAC	914	916	GAC	79;79;79	G;A,C;C	68;65,1;66	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	996	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3854	77.5	1	SNP	p	D95N	0	.	.	283	285	GAC	914	916	GAC	79;79;79	G;A,C;C	68;65,1;66	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	404	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1780	68.1	0	.	p	.	0	A39T	NONSYN	115	117	GCC	707	709	ACC	102;102;103	A;C;C,A	83;85;84,1	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	404	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1780	68.1	0	.	p	.	0	R44H	NONSYN	130	132	CGC	722	724	CAC	100;100;100	C;A;C	84;82;86	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	404	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1780	68.1	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	905	907	CAC	97;99;99	C;A;C	85;89;88	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	404	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1780	68.1	1	SNP	p	G45D	0	.	.	133	135	GGC	725	727	GGC	100;100;100	G;G;C	87;81;84	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	272	mtrR_promoter	250	250	100.0	mtrR_promoter.l6.c17.ctg.1	1500	54.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1062	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3348	94.7	1	SNP	p	D86N	0	.	.	256	258	GAC	820	822	GAC	138;136;138	G;A;C	110;111;111	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1062	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3348	94.7	1	SNP	p	S87W	0	.	.	259	261	AGT	823	825	AGT	139;142;143	A;G;T	113;116;112	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1062	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3348	94.7	1	SNP	p	S87R	0	.	.	259	261	AGT	823	825	AGT	139;142;143	A;G;T	113;116;112	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1062	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3348	94.7	1	SNP	p	S87I	0	.	.	259	261	AGT	823	825	AGT	139;142;143	A;G;T	113;116;112	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1062	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3348	94.7	1	SNP	p	S88P	0	.	.	262	264	TCC	826	828	TCC	143;142;141	T,G;C,A;C	110,1;113,1;116	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	812	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3141	77.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1879	1881	GGC	83;82;82	G,T;G;C	76,1;72;72	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	706	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2748	76.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1493	1495	GCA	114;114;115	G;C;A	96;96;94	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	706	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2748	76.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1496	1498	ATC	116;116;115	A;T,C;C	99;94,1;95	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	706	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2748	76.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1508	1510	GTG	120;120;119	G;T;G	101;98;97	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	706	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2748	76.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1508	1510	GTG	120;120;119	G;T;G	101;98;97	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	706	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2748	76.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2012	2014	ACC	84;83;82	A;C;C	68;67;66	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	706	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2748	76.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2066	2068	GCG	83;83;83	G;C;G	66;56;62	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	706	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2748	76.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2066	2068	GCG	83;83;83	G;C;G	66;56;62	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	706	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2748	76.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2189	2191	GGC	82;84;84	G;G;C	72;75;72	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	706	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2748	76.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2198	2200	GGC	85;85;85	G,C;G;C	74,1;71;74	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	706	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2748	76.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2216	2218	CCG	86;86;88	C;C;G	72;77;72	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	950	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3577	79.6	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1844	1846	CTG	104;104;105	C;T;G	75;80;78	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	502	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2276	65.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	838	838	C	69	C,G	61,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	70	porB1a	984	171	90.29	porB1a.l15.c4.ctg.1	1203	16.9	0	.	p	.	0	H217N	NONSYN	649	651	CAT	1057	1059	AAT	3;3;3	A;A;T	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	70	porB1a	984	171	90.29	porB1a.l15.c4.ctg.1	1203	16.9	0	.	p	.	0	D218N	NONSYN	652	654	GAT	1060	1062	AAT	3;3;3	A;A;T	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	70	porB1a	984	171	90.29	porB1a.l15.c4.ctg.1	1203	16.9	0	.	p	.	0	A222V	NONSYN	664	666	GCT	1072	1074	GTT	2;2;2	G;T;T	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	70	porB1a	984	171	90.29	porB1a.l15.c4.ctg.1	1203	16.9	0	.	p	.	0	V226A	NONSYN	676	678	GTA	1084	1086	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	70	porB1a	984	171	90.29	porB1a.l15.c4.ctg.1	1203	16.9	0	.	p	.	0	.	MULTIPLE	700	702	ACT	1107	1109	GTA	1;1;1	G;T;A	1;1;1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	70	porB1a	984	171	90.29	porB1a.l15.c4.ctg.1	1203	16.9	0	.	p	.	0	D238fs	FSHIFT	712	712	G	1119	1119	G	1	G	1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	486	porB1b	1035	1035	95.63	porB1b.l6.c17.ctg.1	1954	73.6	0	.	p	.	0	E48G	NONSYN	142	144	GAA	663	665	GGA	95;95;95	G;G;A	79;80;83	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	486	porB1b	1035	1035	95.63	porB1b.l6.c17.ctg.1	1954	73.6	0	.	p	.	0	G50N	NONSYN	148	150	GGC	669	671	AAC	99;99;99	A;A;C	89;86;87	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	486	porB1b	1035	1035	95.63	porB1b.l6.c17.ctg.1	1954	73.6	0	.	p	.	0	F135L	NONSYN	403	405	TTT	924	926	CTT	99;100;100	C;T,A;T,G	78;73,1;75,2	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	486	porB1b	1035	1035	95.63	porB1b.l6.c17.ctg.1	1954	73.6	0	.	p	.	0	R143G	NONSYN	427	429	AGA	948	950	GGA	96;96;96	G;G;A	79;77;75	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	486	porB1b	1035	1035	95.63	porB1b.l6.c17.ctg.1	1954	73.6	0	.	p	.	0	D171G	NONSYN	511	513	GAT	1032	1034	GGT	96;96;96	G;G;T	83;85;83	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	486	porB1b	1035	1035	95.63	porB1b.l6.c17.ctg.1	1954	73.6	0	.	p	.	0	G189S	NONSYN	565	567	GGC	1086	1088	AGC	99;99;99	A;G;C	86;89;87	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	486	porB1b	1035	1035	95.63	porB1b.l6.c17.ctg.1	1954	73.6	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1152	1152	T	99	T	79	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	486	porB1b	1035	1035	95.63	porB1b.l6.c17.ctg.1	1954	73.6	1	SNP	p	G120K	0	.	.	358	360	GGT	879	881	GGT	95;95;95	G;G,T;T	77;74,1;74	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	486	porB1b	1035	1035	95.63	porB1b.l6.c17.ctg.1	1954	73.6	1	SNP	p	A121D	0	.	.	361	363	GCC	882	884	GCC	95;96;96	G;C;C	75;76;76	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	486	porB1b	1035	1035	95.63	porB1b.l6.c17.ctg.1	1954	73.6	1	SNP	p	A121N	0	.	.	361	363	GCC	882	884	GCC	95;96;96	G;C;C	75;76;76	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1920	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5252	109.4	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2179	2181	AAT	126;126;126	A;A;T	106;105;101	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	398	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1565	76.0	1	SNP	p	V57M	1	.	.	169	171	ATG	793	795	ATG	163;163;163	A;T,C;G	128;129,1;130	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
